Clinical trial
A Pilot Open-Label Prospective Study of Safety and Preliminary Efficacy of Endoscopic Submucosal Injection of Hyaluronic Acid Into the Bladder Wall in Patients With Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)
NCT07658118 is registered in ClinicalTrials.gov with Sverdlovsk Regional Clinical Hospital No.1 as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Open-Label Prospective Study of Safety and Preliminary Efficacy of Endoscopic Submucosal Injection of Hyaluronic Acid Into the Bladder Wall in Patients With Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)
- Lead sponsor
- Sverdlovsk Regional Clinical Hospital No.1
- Phase
- Phase 1
- Overall status
- Not yet recruiting
- Start date
- July 31, 2026
- Completion date
- January 31, 2027
- Enrollment
- 15 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.